Petros Pharmaceuticals PTPI Balance Sheet (2020-2026)

OTC PTPI
$0.00 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT
Reported Financials

Petros Pharmaceuticals Quarterly Balance Sheet

Periods 26 quarters
Latest Jun 2026

Petros Pharmaceuticals reported total assets of $3.55M and total liabilities of $2.84M for the quarter ended Jun 2026, down 52.1% year over year. This balance sheet covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
8.14M23.85M17.67M13.30M11.18M9.43M8.32M7.38M17.97M13.34M11.10M7.50M3.90M1.72M8.93M7.32M6.10M5.14M4.40M3.50M
Cash & Current Investments
8.14M23.85M17.67M13.30M11.18M9.43M8.32M7.38M17.97M13.34M11.10M7.50M3.90M1.72M8.93M7.32M6.10M5.14M4.40M3.50M
Receivables - NetNet Receivables
1.95M2.46M3.74M5.75M3.73M2.11M2.40M2.58M2.98M2.23M1.96M1.78M1.95M0.42M
Receivables
1.95M2.46M3.74M5.75M3.73M2.11M2.40M2.58M2.98M2.23M1.96M1.78M1.95M0.42M
Raw Materials
0.36M1.48M1.57M1.91M2.08M2.39M1.43M1.41M1.32M1.26M1.26M
Finished Goods
0.16M0.67M0.24M0.13M0.10M0.11M0.18M0.14M0.11M0.15M0.09M
Inventory
0.52M0.52M1.94M1.91M2.15M1.82M2.04M2.18M2.50M1.61M1.56M1.43M1.41M1.35M
Prepaid Assets
2.75M3.72M3.48M1.90M1.70M1.32M1.15M1.01M0.99M2.03M2.12M1.89M1.83M885.000.05M0.08M0.06M0.03M0.04M0.06M
Current Assets
13.35M30.54M26.84M22.85M18.77M14.67M13.90M13.15M24.43M20.39M17.90M13.98M10.72M7.29M14.47M7.40M6.13M5.16M4.39M3.55M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
0.05M0.05M0.05M0.04M0.04M0.04M0.04M0.03M0.03M0.03M0.03M0.02M0.02M0.02M
Intangibles
26.98M25.29M23.73M22.18M13.16M12.24M11.42M10.60M9.77M8.97M8.26M7.54M6.83M3.20M
Goodwill & Intangibles
26.98M25.29M23.73M22.18M13.16M12.24M11.42M10.60M9.77M8.97M8.26M7.54M6.83M3.20M
Other Non-Current Assets
0.50M0.48M0.45M0.42M0.39M0.36M0.33M0.29M3.34M3.14M
Non-Current Assets
38.68M36.85M29.03M28.20M18.92M17.75M16.67M15.58M14.48M13.41M12.41M11.19M9.97M3.34M3.14M
Assets
52.04M67.39M55.86M51.05M37.70M32.42M30.57M28.73M38.91M33.80M30.31M25.17M20.69M10.64M17.61M7.40M6.13M5.16M4.39M3.55M
Liabilities
Current Liabilities
Accounts Payables
5.31M4.56M3.70M1.90M2.08M1.81M1.86M1.78M1.36M1.71M2.14M0.79M1.60M0.76M0.76M0.97M0.42M0.08M0.13M0.10M
Notes Payables
0.72M0.90M0.91M1.09M1.11M1.12M1.14M1.16M1.55M1.94M2.33M7.25M
Payables
5.31M4.56M4.42M2.81M2.99M2.90M2.96M2.91M2.49M2.87M3.69M2.73M3.93M8.01M0.76M0.97M0.42M0.08M0.13M0.10M
Accumulated Expenses
11.59M11.96M5.51M4.01M4.48M3.63M3.61M4.78M3.87M5.36M6.33M6.67M6.54M0.10M0.20M0.26M0.51M0.14M0.19M0.22M
Other Accumulated Expenses
1.26M0.26M0.47M0.56M0.47M0.54M0.31M0.78M0.44M0.49M0.36M0.35M0.35M941.000.00M225.00448.00135.00202.00
Short term Debt
1.74M
Total Current Liabilities
33.50M30.98M10.29M7.38M7.94M7.07M6.89M7.97M8.08M10.77M11.22M9.98M12.56M18.03M27.13M2.95M2.77M2.29M2.62M2.84M
Non-Current Liabilities
Non-Current Debt
9.48M9.12M8.76M8.39M8.01M7.63M7.25M14.86M6.46M5.70M4.92M7.20M
Preferred Stock Liabilities
0.00M0.12M0.41M0.91M1.12M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Liabilities from Discontinued OperationsLiabilities from Discont. Ops
0.08M0.06M
Other Non-Current Liabilities
0.69M0.87M0.37M0.34M0.30M0.26M0.22M0.18M6.72M3.69M1.94M0.31M0.09M8.29M0.00M0.00M900.00900.0013.60M
Total Non-Current Liabilities
33.50M30.98M19.77M16.50M16.70M15.46M14.90M15.60M25.26M18.04M18.59M16.79M17.49M18.10M18.90M2.95M2.76M2.29M2.62M-10.76M
Total Liabilities
34.19M31.85M20.14M16.83M17.00M15.72M15.12M15.78M31.98M21.72M20.53M17.10M17.58M18.10M27.19M2.95M2.77M2.29M2.62M2.84M
Shareholder's Equity
Total Debt
1.74M10.20M10.02M9.66M9.48M9.12M8.76M8.39M16.01M8.01M7.63M7.25M14.45M
Common Equity
17.85M35.54M35.73M34.22M20.69M16.70M15.45M12.94M6.93M12.07M9.79M8.07M3.12M-7.47M-9.58M4.45M3.37M2.87M1.77M0.70M
Liabilities and Shareholders Equity
52.04M67.39M55.86M51.05M37.70M32.42M30.57M28.73M38.91M33.80M30.31M25.17M20.69M10.64M17.61M7.40M6.13M5.16M4.39M3.55M
Retained Earnings
-62.50M-70.69M-70.90M-73.00M-86.51M-90.73M-92.11M-94.70M-99.21M-98.89M-101.10M-101.71M-103.93M-113.21M-115.50M-110.04M-111.00M-111.29M-112.30M-113.24M

Petros Pharmaceuticals Balance Sheet API

Pull Petros Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PTPI&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY